Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19909200 | 0.95 | STS (0.34) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL22563387 | 0.92 | STS (0.34) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL19909049 | 0.89 | STS (0.36) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL21279084 | 0.89 | STS (0.32) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL22170313 | 0.87 | CYP11B2 (0.37) | CYP11B1CYP11B2ALDH1A1TSHRRECQL | |
| SCHEMBL21108358 | 0.87 | STS (0.34) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL22563385 | 0.87 | ABCG2 (0.35) | STSALDH1A1KDM4EHPGDFFAR4 | |
| SCHEMBL19909393 | 0.87 | STS (0.35) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL19909096 | 0.87 | STS (0.35) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL22562399 | 0.87 | TGFBR1 (0.40) | METAP2GABRA1GABRG2GABRB3GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-21 | — | — | US | disclosed |
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2020-05-26 | — | — | US | disclosed |
| US-20180062085-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| EP-3287451-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OPRM1, OR51E2 | STS 2528/4885CYP11B1 610/4885CYP11B2 402/4885 |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | OR10J3, CFD, AOX1 | STS 2306/4885CYP11B1 1400/4885CYP11B2 965/4885 |
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OPRM1, OR51E2 | STS 2528/4885CYP11B1 610/4885CYP11B2 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.